Harmony Biosciences Amends 2023 10-K for Executive Compensation Details

TL;DR

**Harmony Biosciences just amended its 10-K to clarify executive compensation for Kapadia and Dierks for 2023.**

AI Summary

Harmony Biosciences Holdings, Inc. filed a Form 10-K/A on February 28, 2024, amending its annual report for the fiscal year ended December 31, 2023. The amendment specifically details changes related to Sandip Kapadia's original and modified compensation plans, as well as information concerning Jeffrey Dierks. The filing indicates a focus on executive compensation disclosures for the period from October 1, 2023, to December 31, 2023.

Why It Matters

This amendment provides updated transparency on executive compensation structures for key personnel, which can influence investor perception and corporate governance evaluations.

Risk Assessment

Risk Level: low — The filing is an amendment to an annual report, primarily for clarification of executive compensation, which is a routine disclosure and does not indicate new significant risks.

Key Numbers

• 2023-12-31 — Fiscal Year End (The period for which the annual report and amendment apply.)
• 2024-02-28 — Filed As Of Date (The date the 10-K/A amendment was filed.)
• 001-39450 — SEC File Number (Harmony Biosciences' SEC registration number.)

Key Players & Entities

• Harmony Biosciences Holdings, Inc. (company) — filer
• Sandip Kapadia (person) — executive with compensation plan details
• Jeffrey Dierks (person) — executive mentioned in filing
• 03 Life Sciences (company) — organization name

FAQ

From the Filing

0001558370-24-002037.txt : 20240228 0001558370-24-002037.hdr.sgml : 20240228 20240228171627 ACCESSION NUMBER: 0001558370-24-002037 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc. CENTRAL INDEX KEY: 0001802665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822279923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39450 FILM NUMBER: 24696901 BUSINESS ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: (484) 539-9800 MAIL ADDRESS: STREET 1: 630 W GERMANTOWN PIKE STREET 2: SUITE 215 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 10-K/A 1 hrmy-20231231x10ka.htm 10-K/A 0001802665 FY true 0001802665 hrmy:SandipKapadiaMember hrmy:OriginalPlanMember 2023-12-31 0001802665 hrmy:SandipKapadiaMember hrmy:ModifiedPlanMember 2023-12-31 0001802665 hrmy:JeffreyDierksMember 2023-12-31 0001802665 hrmy:SandipKapadiaMember hrmy:OriginalPlanMember 2023-10-01 2023-12-31 0001802665 hrmy:SandipKapadiaMember hrmy:ModifiedPlanMember 2023-10-01 2023-12-31 0001802665 2023-10-01 2023-12-31 0001802665 hrmy:SandipKapadiaMember 2023-10-01 2023-12-31 0001802665 hrmy:JeffreyDierksMember 2023-10-01 2023-12-31 0001802665 2023-06-30 0001802665 2024-02-16 0001802665 2023-01-01 2023-12-31 xbrli:shares iso4217:USD ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  10-K/A (Amendment No.1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from                    to Commission File Number: 001-39450 HARMONY BIOSCIENCES HOLDINGS, INC. (Exact name of registrant as specified in its charter) ​ ​ ​ Delaware 82-2279923 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 630 W. Germantown Pike , Suite 215 , Plymouth Meeting , PA 19462 (Address of principal executive offices) (Zip Code) ​ ​ ​ ( 484 ) 539-9800 (Registrant’s telephone number, including area code) ​ Securities registered pursuant to Section 12(b) of the Act: ​ ​ ​ ​ ​ ​ ​ ​ Trading ​ Name of each exchange Title of each class      Symbol(s)      on which registered Common Stock, par value $0.00001 value per share ​ HRMY ​ The Nasdaq Stock Market LLC ​ ​ ​ ​ (Nasdaq Global Market) Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes   ☒  No  ☐   Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ☐   No   ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pu